What the results of Wegovy’s longest clinical trial yet show about ...
网页2024年5月13日 — The results showed that the 10% average weight loss for people using Wegovy was sustained for up to 208 weeks, or four years. Patients stayed on the medicine while they sustained the weight...
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
网页2023年8月25日 — The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement of 17 points on a...
New Analysis Confirms Wegovy Can Sustain Weight Loss for 4 …
网页2024年5月22日 — A new analysis shows that Wegovy is effective for long-term weight loss, with users maintaining weight loss for at least four years. The medication shows significant cardiovascular benefits and appears to reduce the risk of heart disease independently of weight loss.
Wegovy users keep weight off for 4 years, new analysis finds
网页2024年5月14日 — Reuters. Patients taking Novo Nordisk’s Wegovy obesity treatment maintained an average of 10% weight loss after four years, potentially boosting the drugmaker’s case to insurers and governments...
FDA Approves First Treatment to Reduce Risk of Serious Heart …
网页“Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or...
FDA Approves New Drug Treatment for Chronic Weight …
网页FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Roche to accelerate Wegovy weight loss rivals after positive trials
网页2024年7月29日 — Swiss pharma giant Roche to accelerate Wegovy rival drugs after positive trial data. Swiss pharmaceutical giant Roche said Monday it is accelerating the development of its Wegovy rival weight loss ...
FDA approves Wegovy, a new drug to fight obesity - CBS News
网页2021年6月10日 — The FDA on Friday approved a new weight-loss drug, Wegovy, for people who are either obese or overweight and have at least one weight-related medical problem.
Novo's Wegovy shows heart benefit alongside weight loss in trial
网页2023年8月8日 — Wegovy maker Novo Nordisk said on Tuesday a large study had shown the highly effective obesity treatment also had a clear cardiovascular benefit, boosting the Danish company's hopes of moving...
Where Ozempic, Wegovy and New Weight Loss Drugs Came From …
网页2023年8月17日 — And results from a clinical trial reported last week indicate that Wegovy can do more than help people lose weight — it also can protect against cardiac complications, like heart attacks and...